During the past decade, Complejo Hospitalario de Toledo conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 2 clinical trials were completed, i.e. on average, 10.5% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Complejo Hospitalario de Toledo" #1 sponsor was "PETHEMA Foundation" with 5 trials, followed by "Grupo Español de Rehabilitación Multimodal" with 3 trials sponsored, "Fundacion SEIMC-GESIDA" with 2 trials sponsored, "Fundación GECP" with 2 trials sponsored and "Fundación Médica para la Investigación y Desarrollo en el Area Cardiovascular" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Complejo Hospitalario de Toledo" #1 collaborator was "Abbott Medical Devices" with 3 trials as a collaborator, "B.Braun Surgical SA" with 2 trials as a collaborator, "Hospital San Carlos, Madrid" with 2 trials as a collaborator, "Adknoma" with 1 trials as a collaborator and "Beth Israel Deaconess Medical Center" with 1 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Complejo Hospitalario de Toledo" are "Perioperative Care" (3 trials), "Postoperative Complications" (3 trials), "COVID-19" (2 trials), "Carotid Stenosis" (2 trials) and "HIV Infections" (2 trials). Many other conditions were trialed in "Complejo Hospitalario de Toledo" in a lesser frequency.

Most popular intervention types in "Complejo Hospitalario de Toledo" are "Drug" (10 trials), "Device" (5 trials), "Procedure" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (4 trials), "Bortezomib" (2 trials), "Coronary angioplasty using the paclitaxel-eluting balloon" (2 trials), "Lenalidomide" (2 trials) and "Atezolizumab-Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Complejo Hospitalario de Toledo" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Complejo Hospitalario de Toledo". 1 are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Complejo Hospitalario de Toledo, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Complejo Hospitalario de Toledo, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".